VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's Disease: A Prospective Observational Study
Clinical trial NCT06249555 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06249555
- Sponsor
- Alimentiv Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-03-20
- Primary completion
- 2026-09-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.